Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC)

PHASE2UnknownINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 30, 2018

Study Completion Date

December 30, 2018

Conditions
Ischemic Stroke
Interventions
DRUG

Neu2000KWL High-does group

1st infusion of 750mg in patients receiving endovascular therapy within 8 hours following ischemic stroke onset followed by 9 consecutive infusions of 500 mg at intervals of 12 hours

DRUG

Neu2000KWL Low-does group

1st infusion of 500mg in patients receiving endovascular therapy within 8 hours following ischemic stroke onset followed by 9 consecutive infusions of 250 mg at intervals of 12 hours

DRUG

Placebo

1st infusion of the same volume of saline in patients receiving endovascular therapy within 8 hours following ischemic stroke onset followed by 9 consecutive infusions of same volume of saline at intervals of 12 hours

Trial Locations (6)

16499

RECRUITING

Ajou University Hospital, Seoul

21565

RECRUITING

Gachon University Gil Medical Center, Incheon

28644

RECRUITING

Chungbuk National University Hospital, Cheongju-si

41931

RECRUITING

Keimyung University Dongsan Medical Center, Daegu

41944

RECRUITING

Kyungpook National University Hospital, Daegu

61453

RECRUITING

Chosun University Hospital, Gwangju

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GNT Pharma

INDUSTRY